XML 30 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flow from operating activities      
Net loss $ (49,594) $ (53,082) $ (17,970)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation expense 3,874 495 90
Depreciation and amortization 3,664 2,612 1,314
Share of loss from equity method investee 886 416 0
Gain on deemed sale from equity method investee (1,229) 0 0
(Accretion of discounts) amortization of premiums on investments (1,752) 0 0
Other non-operating income (177) (98) 0
Changes in operating assets and liabilities      
Amounts owed by a related party (58) 380 0
Prepaid expenses and other current assets (1,180) (751) (602)
Other long-term assets (80) (6) (200)
Accounts payable (69) (267) 3,569
Accrued liabilities 3,497 1,582 808
Other current liabilities 43 (136) 647
Deferred revenue (353) 23,587 0
Deferred rent (468) 209 (600)
Net cash used in operating activities (42,996) (25,059) (12,944)
Cash flow from investing activities      
Purchases of short-term and long-term investments (261,552) (96,830) (33,762)
Proceeds from maturities of short-term and long-term investments 151,855 53,273 0
Purchases of property and equipment (3,743) (5,514) (4,099)
Investment in related party 0 0 (1,000)
Net cash used in investing activities (113,440) (49,071) (38,861)
Cash flow from financing activities      
Proceeds from initial public offering, net of issuance costs 125,111 0 0
Proceeds from issuance of preferred stock, net of issuance costs 0 106,877 69,817
Proceeds from issuance of common stock upon exercise of stock options, net of repurchases 4,098 892 283
Deferred initial public offering costs 0 (373) 0
Payment of preferred stock issuance costs (135) 0 0
Net cash provided by financing activities 129,074 107,396 70,100
Net decrease in cash and cash equivalents (27,362) 33,266 18,295
Cash and cash equivalents at beginning of period 98,426 65,160 46,865
Cash and cash equivalents at end of period 71,064 98,426 65,160
Non-cash investing and financing activities:      
Unpaid financing cost included in accounts payable and accrued liabilities 0 1,058 0
Unpaid portion of property and equipment purchases included in accounts payable and accrued liabilities 136 338 618
Vesting of early exercised stock options and restricted stock $ 1,276 $ 235 $ 63